ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于2025年度日常关联交易预计公告 | 2025-04-28 | Chinese | |
| 2024年环境、社会及管治（ESG）报告 | 2025-04-28 | Chinese | |
| 2024年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-04-28 | Chinese | |
| 监事会关于公司2025年限制性股票激励计划（草案）的核查意见 | 2025-04-28 | Chinese | |
| 监事会决议公告 | 2025-04-28 | Chinese | |
| 独立董事2024年度述职报告（杨凌） | 2025-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36044551 | 关于2025年度日常关联交易预计公告 | 2025-04-28 | Chinese | ||
| 36044548 | 2024年环境、社会及管治（ESG）报告 | 2025-04-28 | Chinese | ||
| 36044429 | 2024年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-04-28 | Chinese | ||
| 36044421 | 监事会关于公司2025年限制性股票激励计划（草案）的核查意见 | 2025-04-28 | Chinese | ||
| 36044413 | 监事会决议公告 | 2025-04-28 | Chinese | ||
| 36044405 | 独立董事2024年度述职报告（杨凌） | 2025-04-28 | Chinese | ||
| 36044398 | 2024年年度审计报告 | 2025-04-28 | Chinese | ||
| 36044324 | 北京市竞天公诚律师事务所上海分所关于睿智医药科技股份有限公司2025年限制性股票激励计划（草案）之法律意见书 | 2025-04-28 | Chinese | ||
| 36044310 | 独立董事公开征集委托投票权报告书的公告 | 2025-04-28 | Chinese | ||
| 36044301 | 2024年年度报告 | 2025-04-28 | Chinese | ||
| 36044231 | 董事会决议公告 | 2025-04-28 | Chinese | ||
| 36044224 | 薪酬与考核委员会关于公司2025年限制性股票激励计划（草案）的核查意见 | 2025-04-28 | Chinese | ||
| 36044217 | 关于睿智医药科技股份有限公司2024年度营业收入扣除情况表的鉴证报告 | 2025-04-28 | Chinese | ||
| 36044210 | 2024年度内部控制审计报告 | 2025-04-28 | Chinese | ||
| 36044203 | 董事会对独董独立性评估的专项意见 | 2025-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.